Dolby Laboratories (DLB) Misses Q2 EPS by 5c; Guides Q3 Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts DLB Hot Sheet
Price: $63.28 --0%
Revenue Growth %: +21.4%
Financial Fact:
Operating income: 29.09M
Today's EPS Names:
DD, ARDS, OMID, More
Revenue Growth %: +21.4%
Financial Fact:
Operating income: 29.09M
Today's EPS Names:
DD, ARDS, OMID, More
Join SI Premium – FREE
Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $1.04, $0.05 worse than the analyst estimate of $1.09. Revenue for the quarter came in at $351.8 million versus the consensus estimate of $361.35 million.
GUIDANCE:
Dolby Laboratories sees Q3 2020 EPS of $0.18-$0.35, versus the consensus of $0.72. Dolby Laboratories sees Q3 2020 revenue of $225-250 million, versus the consensus of $309.08 million.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Columbus McKinnon (CMCO) Tops Q2 EPS by 23c ; Offers Guidance
- Henry Schein (HSIC) Tops Q3 EPS by 20c ; Offers Guidance
- Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
